Acadian Asset Management LLC Synthetic Biologics, Inc. Transaction History

Acadian Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$5.0 - $11.7 $363,945 - $851,631	-72,789 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$4.5 - $7.1 $53,014 - $83,645	11,781 Added 19.31%	72,789 $35,000
Q2 2020 Aug 12, 2020	BUY	$2.8 - $5.7 $170,822 - $347,745	61,008 New	61,008 $31,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.